Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.68 |
| ▸ | NAAA | Q02083 | 2/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26670015 | 0.82 | EPHX1 (0.64) | EPHX1NAAAHTTCYP2C19ALDH1A1 | |
| SCHEMBL30541899 | 0.82 | EPHX1 (0.46) | EPHX1NAAAGPR35CYP19A1 | |
| SCHEMBL967579 | 0.81 | EPHX1 (1.00) | EPHX1NAAAHTTCYP2C19ALDH1A1 | |
| SCHEMBL18186686 | 0.79 | EPHX1 (0.53) | EPHX1NAAAGPR35HTTCYP2C19 | |
| SCHEMBL3927732 | 0.79 | EPHX1 (0.53) | EPHX1NAAAGPR35HTTCYP2C19 | |
| SCHEMBL965658 | 0.79 | EPHX1 (0.96) | EPHX1NAAAHTTCYP2C19ALDH1A1 | |
| SCHEMBL6950279 | 0.76 | SMN1; SMN2 (0.58) | EPHX1NAAAGPR35CYP2C19ALDH1A1 | |
| SCHEMBL3020222 | 0.76 | NAAA (0.54) | EPHX1NAAAGPR35HTTCYP2C19 | |
| SCHEMBL2999385 | 0.75 | EPHX1 (0.54) | EPHX1NAAAGPR35HTTCYP2C19 | |
| SCHEMBL15777906 | 0.75 | EPHX1 (0.89) | EPHX1NAAAHTTALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11491091-B2 | Cooling product | SYMRISE AG (DE) | 2022-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11491091-B2 | Cooling product | TRPA1, TRPV2, TRPV1 | EPHX1 1461/4885NAAA 341/4885GPR35 3635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.